• Contact: +91-9643310025, 9643312749
  • Generic selectors
    Exact matches only
    Search in title
    Search in content
    Search in posts
    Search in pages
    Filter by Categories
    Annual brand plans
    Autoimmune diseases
    Conference support
    Corporate strategy and R & D consulting
    KOL support
    MSL training
    Orphan Diseases
    Pre-& post launch activities
    Sales & marketing
    Sales force training
Author: PK Gupta Email: [email protected] Published on 03/Jan/2021 Most people who have coronavirus disease 2019 (COVID-19) recover completely within a few weeks. But some people — even those who had mild versions of the disease — continue to experience symptoms after their initial recovery. These people sometimes describe themselves as “long haulers” and the condition has been called post-COVID-19 syndrome or “long COVID-19.” The syndrome appears to affect those with mild as well as moderate-to-severe disease. The
Summary of ICMRA SARS-CoV-2 Vaccines Workshop #2 The June 22, 2020 teleconference of global regulators convened jointly by EMA and US FDA under the auspices of ICMRA, discussed preclinical and clinical data requirements to support proceeding to Phase 3 clinical trials with SARS-CoV-2 vaccine candidates. In addition, participants discussed concepts of trial design for these studies including trial population, endpoints and statistical considerations. The following represents generally agreed positions among global regulators in attendance. Pre-clinical

CORONIL: A New Hope for COVID-19 Management

Posted by pharmintel on July 4, 2020

Category: Blog
COVID-19 is an emerging global viral infection, originating from Wuhan, China in December 20191. There is no proven effective curable management for COVID-19. However, developments in the treatment of COVID-19 are in progress. Understanding immunopathogenesis of COVID-19 is very important for developing efficient treatment regimens. There are a rapidly increasing number of clinical investigations of different therapeutic approaches for COVID-19. Moreover, a variety of anti-inflammatory agent that can reduce the entry of the virus into
Technology innovation has focused on providing & storing data on real time basis and ensuring security in terms of any data breach. Is it possible for India to store data of 1.3 billion people? If data is stored can it be accessed readily on real time? Does there exists technology to do such a humungous task? Questions are many but solution is one, Blockchain technology, it is secure, safe, real time, transparent and many more
The pandemic, COVID-19 has impacted all kinds of businesses both physically and virtually, but the effect is not uniform in certain aspects. Blockchain technology can play a pivotal role in minimizing the impact of COVID-19 crisis by using digital transforming initiatives and solving the current uprising problems in system. Many sectors are badly hit by COVID-19 but there are some gaps which can definitely be filled using the blockchain technology and aid in the recovery
+91 9643310025, 9643312749
© 2024 Pharmintel